{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:31:29Z","timestamp":1793043089776,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zuomin Wang","award":["Grant No. L232104"],"award-info":[{"award-number":["Grant No. L232104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-06939-7","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:32:47Z","timestamp":1761298367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding the human tongue of light chain amyloidosis in three dimensions (3D): three-dimensional pathological visualization drives early and precise screening of suspected cases"],"prefix":"10.1186","volume":"25","author":[{"given":"Liqiong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"2","key":"6939_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajh.27177","volume":"99","author":"MA Gertz","year":"2024","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment. Am J Hematol. 2024;99(2):309\u201324. https:\/\/doi.org\/10.1002\/ajh.27177.","journal-title":"Am J Hematol"},{"issue":"1","key":"6939_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13023-022-02414-6","volume":"17","author":"N Kumar","year":"2022","unstructured":"Kumar N, Zhang NJ, Cherepanov D, et al. Global epidemiology of amyloid light-chain amyloidosis. Orphanet J Rare Dis. 2022;17(1):278. https:\/\/doi.org\/10.1186\/s13023-022-02414-6.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"6939_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jaccao.2022.08.009","volume":"4","author":"AD Wechalekar","year":"2022","unstructured":"Wechalekar AD, Fontana M, Quarta CC, Liedtke M. AL Amyloidosis for cardiologists: awareness, diagnosis, and future prospects: JACC: Cardio Oncology state-of-the-art review. JACC Cardio Oncol. 2022;4(4):427\u201341. https:\/\/doi.org\/10.1016\/j.jaccao.2022.08.009.","journal-title":"JACC Cardio Oncol"},{"issue":"6","key":"6939_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13061744","volume":"13","author":"A Shafqat","year":"2024","unstructured":"Shafqat A, Elmaleh H, Mushtaq A, et al. Renal AL amyloidosis: updates on diagnosis, staging, and management. J Clin Med. 2024;13(6):1744. https:\/\/doi.org\/10.3390\/jcm13061744.","journal-title":"J Clin Med"},{"issue":"8","key":"6939_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41408-021-00529-w","volume":"11","author":"A Staron","year":"2021","unstructured":"Staron A, Zheng L, Doros G, et al. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood Cancer J. 2021;11(8):139. https:\/\/doi.org\/10.1038\/s41408-021-00529-w.","journal-title":"Blood Cancer J"},{"issue":"20","key":"6939_CR6","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1182\/bloodadvances.2023010324","volume":"7","author":"JN Gustine","year":"2023","unstructured":"Gustine JN, Staron A, Mendelson L, et al. Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis. Blood Adv. 2023;7(20):6080\u201391. https:\/\/doi.org\/10.1182\/bloodadvances.2023010324.","journal-title":"Blood Adv"},{"issue":"1","key":"6939_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41408-024-01040-8","volume":"14","author":"A Singh","year":"2024","unstructured":"Singh A, Szabo A, Lian Q, et al. Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis. Blood Cancer J. 2024;14(1):61. https:\/\/doi.org\/10.1038\/s41408-024-01040-8.","journal-title":"Blood Cancer J"},{"issue":"4","key":"6939_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/ejh.13472","volume":"105","author":"A Schulman","year":"2020","unstructured":"Schulman A, Connors LH, Weinberg J, et al. Patient outcomes in light chain (AL) amyloidosis: the clock is ticking from symptoms to diagnosis. Eur J Haematol. 2020;105(4):495\u2013501. https:\/\/doi.org\/10.1111\/ejh.13472.","journal-title":"Eur J Haematol"},{"issue":"4","key":"6939_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/ejh.13681","volume":"107","author":"S Oubari","year":"2021","unstructured":"Oubari S, Naser E, Papathanasiou M, et al. Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvement. Eur J Haematol. 2021;107(4):449\u201357. https:\/\/doi.org\/10.1111\/ejh.13681.","journal-title":"Eur J Haematol"},{"issue":"3","key":"6939_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3816\/CLML.2010.n.027","volume":"10","author":"CE Chee","year":"2010","unstructured":"Chee CE, Lacy MQ, Dogan A, Zeldenrust SR, Gertz MA. Pitfalls in the diagnosis of primary amyloidosis. Clin Lymphoma Myeloma Leuk. 2010;10(3):177\u201380. https:\/\/doi.org\/10.3816\/CLML.2010.n.027.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"6939_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.ajkd.2008.05.022","volume":"52","author":"SM Soares","year":"2008","unstructured":"Soares SM, Fervenza FC, Lager DJ, Gertz MA, Cosio FG, Leung N. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis. 2008;52(6):1079\u201383. https:\/\/doi.org\/10.1053\/j.ajkd.2008.05.022.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"6939_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3881\/j.issn.1000-503X.2016.06.013","volume":"38","author":"CL Zhang","year":"2016","unstructured":"Zhang CL, Feng J, Cao XX, et al. Selection of biopsy site for patients with systemic amyloidosis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016;38(6):706\u20139. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.2016.06.013.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"12","key":"6939_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.34067\/KID.0000000600","volume":"5","author":"R Chowdhury","year":"2024","unstructured":"Chowdhury R, Shah S, Latcha S, Lobato L. Kidney disease in systemic amyloidosis: a review of amyloid, amyloid serum A protein, leukocyte chemotactic factor 2, and transthyretin amyloid. Kidney360. 2024;5(12):1925\u201337. https:\/\/doi.org\/10.34067\/KID.0000000600.","journal-title":"Kidney360"},{"issue":"12","key":"6939_CR14","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1038\/s41596-019-0240-9","volume":"14","author":"K Matsumoto","year":"2019","unstructured":"Matsumoto K, Mitani TT, Horiguchi SA, et al. Advanced cubic tissue clearing for whole-organ cell profiling. Nat Protoc. 2019;14(12):3506\u201337. https:\/\/doi.org\/10.1038\/s41596-019-0240-9.","journal-title":"Nat Protoc"},{"issue":"4","key":"6939_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.celrep.2016.06.090","volume":"16","author":"T Liebmann","year":"2016","unstructured":"Liebmann T, Renier N, Bettayeb K, et al. Three-dimensional study of Alzheimer\u2019s disease hallmarks using the iDISCO clearing method. Cell Rep. 2016;16(4):1138\u201352. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.090.","journal-title":"Cell Rep"},{"issue":"1","key":"6939_CR16","doi-asserted-by":"publisher","first-page":"9269","DOI":"10.1038\/s41598-017-09117-0","volume":"7","author":"S Nojima","year":"2017","unstructured":"Nojima S, Susaki EA, Yoshida K, et al. CUBIC pathology: three-dimensional imaging for pathological diagnosis. Sci Rep. 2017;7(1):9269. https:\/\/doi.org\/10.1038\/s41598-017-09117-0.","journal-title":"Sci Rep"},{"key":"6939_CR17","volume-title":"Heptinstall\u2019s Pathology of the Kidney","year":"2022","unstructured":"Jennette JC, Olson JL, Silva FG, D\u2019Agati VD, editors. Heptinstall\u2019s Pathology of the Kidney. 8th ed. Philadelphia: Wolters Kluwer; 2022.","edition":"8"},{"issue":"4","key":"6939_CR18","doi-asserted-by":"publisher","first-page":"101286","DOI":"10.1016\/j.bjorl.2023.101286","volume":"89","author":"Y Tao","year":"2023","unstructured":"Tao Y, Qiu X, Ye F, Liao Z, Wu P. Amyloidosis of the tongue: a rare case report. Braz J Otorhinolaryngol. 2023;89(4):101286. https:\/\/doi.org\/10.1016\/j.bjorl.2023.101286.","journal-title":"Braz J Otorhinolaryngol"},{"key":"6939_CR19","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1161\/CIRCULATIONAHA.107.754424","volume":"118","author":"G Buckberg","year":"2008","unstructured":"Buckberg G, et al. Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function. Circulation. 2008;118:2571\u201387.","journal-title":"Circulation"},{"issue":"4","key":"6939_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/jcm11040911","volume":"11","author":"A Stelmach-Go\u0142dy\u015b","year":"2022","unstructured":"Stelmach-Go\u0142dy\u015b A, Zaborek-\u0141yczba M, \u0141yczba J, et al. Physiology, diagnosis and treatment of cardiac light chain amyloidosis. J Clin Med. 2022;11(4):911. https:\/\/doi.org\/10.3390\/jcm11040911.","journal-title":"J Clin Med"},{"key":"6939_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1586\/14779072.2015.1093936","volume":"13","author":"G Palladini","year":"2015","unstructured":"Palladini G, Milani P, Merlini G. Novel strategies for the diagnosis and treatment of cardiac amyloidosis. Expert Rev Cardiovasc Ther. 2015;13:1195\u2013211.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"6939_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00392-019-01490-2","volume":"109","author":"F Escher","year":"2020","unstructured":"Escher F, Senoner M, Doerler J, et al. When and how do patients with cardiac amyloidosis die. Clin Res Cardiol. 2020;109:78\u201388. https:\/\/doi.org\/10.1007\/s00392-019-01490-2.","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"6939_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00380-013-0419-x","volume":"29","author":"RQ Migrino","year":"2014","unstructured":"Migrino RQ, Harmann L, Christenson R, Hari P. Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study. Heart Vessels. 2014;29(6):793\u2013800. https:\/\/doi.org\/10.1007\/s00380-013-0419-x.","journal-title":"Heart Vessels"},{"issue":"6","key":"6939_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/PAP.0b013e3182a92dc3","volume":"20","author":"MM Picken","year":"2013","unstructured":"Picken MM. Modern approaches to the treatment of amyloidosis: the critical importance of early detection in surgical pathology. Adv Anat Pathol. 2013;20(6):424\u201339. https:\/\/doi.org\/10.1097\/PAP.0b013e3182a92dc3.","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"6939_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/ejh.13679","volume":"107","author":"LL Hester","year":"2021","unstructured":"Hester LL, Gifkins DM, Bellew KM, et al. Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019. Eur J Haematol. 2021;107(4):428\u201335. https:\/\/doi.org\/10.1111\/ejh.13679.","journal-title":"Eur J Haematol"},{"issue":"4","key":"6939_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/S10016-005-4616-7","volume":"19","author":"J Seal","year":"2005","unstructured":"Seal J, Gewertz BL, Janczyk RJ, et al. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg. 2005;19(4):572\u201384. https:\/\/doi.org\/10.1007\/S10016-005-4616-7.","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"6939_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/s0344-0338(11)80516-9","volume":"189","author":"A Bohle","year":"1993","unstructured":"Bohle A, Wehrmann M, Eissele R, von Gise H, Mackensen-Haen S, M\u00fcller C. The long-term prognosis of AA and AL renal amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis. Pathol Res Pract. 1993;189(3):316\u201331. https:\/\/doi.org\/10.1016\/s0344-0338(11)80516-9.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"6939_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/13506129.2017.1360272","volume":"24","author":"S Rubinstein","year":"2017","unstructured":"Rubinstein S, Cornell RF, Du L, et al. Novel pathologic scoring tools predict end-stage kidney disease in light chain AL amyloidosis. Amyloid. 2017;24(3):205\u201311. https:\/\/doi.org\/10.1080\/13506129.2017.1360272.","journal-title":"Amyloid"},{"issue":"5","key":"6939_CR29","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s40620-020-00948-1","volume":"34","author":"Y Fan","year":"2021","unstructured":"Fan Y, Liang D, Rui H, et al. Using digital whole-slide images to evaluate renal amyloid deposition and its association with clinical features and outcomes of AL amyloidosis. J Nephrol. 2021;34(5):1747\u201356. https:\/\/doi.org\/10.1007\/s40620-020-00948-1.","journal-title":"J Nephrol"},{"key":"6939_CR30","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1038\/ncomms12474","volume":"7","author":"KH Yu","year":"2016","unstructured":"Yu KH, Zhang C, Berry GJ, et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat Commun. 2016;7:12474. https:\/\/doi.org\/10.1038\/ncomms12474.","journal-title":"Nat Commun"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-06939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-06939-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-06939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:32:49Z","timestamp":1761298369000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-025-06939-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6939"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-06939-7","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Chaoyang Hospital (Approval No. 2023\u201310-25\u20134). Informed consent was obtained from all individual participants included in the study. This study was conducted in accordance with the principles of the Declaration of Helsinki and relevant institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1664"}}